Across TCGA pan-cancer cohorts, MIR369 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR369’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR369 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR369 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.
BRCA are the cancer types where MIR369 tumor–normal differential expression is most reproducible.